Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

Triglycerides and cardiovascular risk.

Harchaoui KE, Visser ME, Kastelein JJ, Stroes ES, Dallinga-Thie GM.

Curr Cardiol Rev. 2009 Aug;5(3):216-22. doi: 10.2174/157340309788970315.

PMID:
20676280
[PubMed]
Free PMC Article
2.

Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy.

Lin Y, Mousa SS, Elshourbagy N, Mousa SA.

Vasc Health Risk Manag. 2010 Mar 3;6:73-85. Review.

PMID:
20234782
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Triglyceride, high density lipoprotein, and coronary heart disease.

[No authors listed]

Consens Statement. 1992 Feb 26-28;10(2):1-28. Review.

PMID:
1286136
[PubMed - indexed for MEDLINE]
4.

High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.

Gotto AM Jr.

Am Heart J. 2002 Dec;144(6 Suppl):S33-42. Review.

PMID:
12486414
[PubMed - indexed for MEDLINE]
5.

Non-HDL cholesterol as a measure of atherosclerotic risk.

Packard CJ, Saito Y.

J Atheroscler Thromb. 2004;11(1):6-14. Review.

PMID:
15067193
[PubMed - indexed for MEDLINE]
Free Article
6.

Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease.

Miller M, Ginsberg HN, Schaefer EJ.

Am J Cardiol. 2008 Apr 1;101(7):1003-8. doi: 10.1016/j.amjcard.2007.11.046. Review.

PMID:
18359322
[PubMed - indexed for MEDLINE]
7.

Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.

Breuer HW.

Curr Med Res Opin. 2001;17(1):60-73. Review.

PMID:
11464448
[PubMed - indexed for MEDLINE]
8.

Triglycerides are more important in atherosclerosis than epidemiology has suggested.

Durrington PN.

Atherosclerosis. 1998 Dec;141 Suppl 1:S57-62. Review.

PMID:
9888644
[PubMed - indexed for MEDLINE]
9.

Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL.

Stalenhoef AF, de Graaf J.

Curr Opin Lipidol. 2008 Aug;19(4):355-61. doi: 10.1097/MOL.0b013e328304b63c. Review.

PMID:
18607182
[PubMed - indexed for MEDLINE]
10.

Evidence that triglycerides are an independent coronary heart disease risk factor.

Cullen P.

Am J Cardiol. 2000 Nov 1;86(9):943-9. Review.

PMID:
11053704
[PubMed - indexed for MEDLINE]
11.

Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.

Chapman MJ, Assmann G, Fruchart JC, Shepherd J, Sirtori C; European Consensus Panel on HDL-C.

Curr Med Res Opin. 2004 Aug;20(8):1253-68. Review.

PMID:
15324528
[PubMed - indexed for MEDLINE]
12.

The triglyceride-high-density lipoprotein axis: an important target of therapy?

Szapary PO, Rader DJ.

Am Heart J. 2004 Aug;148(2):211-21. Review.

PMID:
15308990
[PubMed - indexed for MEDLINE]
13.

HDL and triglyceride as therapeutic targets.

Fruchart JC, Duriez P.

Curr Opin Lipidol. 2002 Dec;13(6):605-16. Review.

PMID:
12441884
[PubMed - indexed for MEDLINE]
14.

Targeting triglycerides as prognostic indicators and determining lowest values for patient benefit.

Sprecher DL.

Curr Cardiol Rep. 2001 Sep;3(5):424-32. Review.

PMID:
11504580
[PubMed - indexed for MEDLINE]
15.

Triglycerides and coronary risk.

Gaziano JM.

Curr Cardiol Rep. 1999 Jul;1(2):125-30. Review.

PMID:
10980831
[PubMed - indexed for MEDLINE]
16.

Cholesterol and atherosclerosis: a contemporary perspective.

Kashyap ML.

Ann Acad Med Singapore. 1997 Jul;26(4):517-23. Review.

PMID:
9395824
[PubMed - indexed for MEDLINE]
17.

Role of fibric acid derivatives in the management of risk factors for coronary heart disease.

Després JP, Lemieux I, Robins SJ.

Drugs. 2004;64(19):2177-98. Review.

PMID:
15456334
[PubMed - indexed for MEDLINE]
18.

Cardiovascular disease and dyslipidemia: beyond LDL.

Pöss J, Custodis F, Werner C, Weingärtner O, Böhm M, Laufs U.

Curr Pharm Des. 2011;17(9):861-70. Review.

PMID:
21418031
[PubMed - indexed for MEDLINE]
19.

Triglycerides and atherogenic lipoproteins: rationale for lipid management.

Krauss RM.

Am J Med. 1998 Jul 6;105(1A):58S-62S. Review.

PMID:
9707269
[PubMed - indexed for MEDLINE]
20.

Fenofibrate: a review of its lipid-modifying effects in dyslipidemia and its vascular effects in type 2 diabetes mellitus.

Keating GM.

Am J Cardiovasc Drugs. 2011 Aug 1;11(4):227-47. doi: 10.2165/11207690-000000000-00000. Review.

PMID:
21675801
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk